Literature DB >> 1975778

Lack of association of T cell receptor beta-chain constant region polymorphism with insulin-dependent diabetes mellitus in Finland.

H Reijonen1, S Silvennoinen-Kassinen, J Ilonen, M Knip.   

Abstract

Allelic polymorphism in the T cell receptor constant beta-chain gene region has been reported to be associated with autoimmune diseases, including insulin-dependent diabetes mellitus (IDDM). The present analysis of 164 children and adolescents with IDDM and 193 controls for BqlII polymorphism using a TcR-C beta cDNA probe revealed two allelic restriction fragments with sizes of 10.5 kb (U) and 9.6 kb (L). No particular association was observed between the RFLP genotypes and IDDM (UU 27% versus 31%; UL 53% versus 52%; and LL 20% versus 17%, in diabetic subjects and controls, respectively), nor were any differences found between patients with various HLA risk antigens. The frequency of heterozygotes was 52% in 63 DR3-positive diabetic subjects and 53% in 73 DR3-negative ones. The results do not support any involvement of the TcR constant region genes in susceptibility to IDDM.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975778      PMCID: PMC1534979          DOI: 10.1111/j.1365-2249.1990.tb05345.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus.

Authors:  O Cohen-Haguenauer; E Robbins; C Massart; M Busson; I Deschamps; J Hors; J M Lalouel; J Dausset; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 3.  The HLA-IDDM association: implications for etiology and pathogenesis of IDDM.

Authors:  J Nerup; T Mandrup-Poulsen; J Mølvig
Journal:  Diabetes Metab Rev       Date:  1987-07

Review 4.  HLA and T-cell receptor genes in insulin-dependent diabetes mellitus.

Authors:  M L Hoover; J D Capra
Journal:  Diabetes Metab Rev       Date:  1987-07

Review 5.  The genetic susceptibility to type I (insulin-dependent) diabetes mellitus.

Authors:  A G Cudworth; E Wolf
Journal:  Clin Endocrinol Metab       Date:  1982-07

6.  Segregation of polymorphic T-cell receptor genes in human families.

Authors:  M A Robinson; T J Kindt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

7.  Thyroglobulin antibodies in Graves' disease are associated with T-cell receptor beta chain and major histocompatibility complex loci.

Authors:  A G Demaine; S Ratanachaiyavong; R Pope; D Ewins; B A Millward; A M McGregor
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

8.  Can future type I diabetes be predicted? A study in families of affected children.

Authors:  A N Gorsuch; K M Spencer; J Lister; E Wolf; G F Bottazzo; A G Cudworth
Journal:  Diabetes       Date:  1982-10       Impact factor: 9.461

9.  The epidemiology of insulin-dependent diabetes mellitus (IDDM) in Finland and in northern Europe.

Authors:  H K Akerblom; A Reunanen
Journal:  Diabetes Care       Date:  1985 Sep-Oct       Impact factor: 19.112

10.  HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals.

Authors:  D Owerbach; A Lernmark; P Platz; L P Ryder; L Rask; P A Peterson; J Ludvigsson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

View more
  2 in total

Review 1.  The immunologic insult in type 1 diabetes.

Authors:  M C Honeyman; L C Harrison
Journal:  Springer Semin Immunopathol       Date:  1993

2.  The immunoglobulin heavy-chain variable region in insulin-dependent diabetes mellitus: affected-sib-pair analysis and association studies.

Authors:  R Veijola; M Knip; R Puukka; H Reijonen; D W Cox; J Ilonen
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.